Rate of 6-[18F]fluorodopa uptake decline in striatal subregions in Parkinson's disease (Q34827117)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Rate of 6-[18F]fluorodopa uptake decline in striatal subregions in Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Moo K. Chung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Barbara B Bendlin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Donald G McLaren

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Catherine L Gallagher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Terrence R Oakes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

James E Holden

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Guofan Xu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Robert J Nickles

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Robert Pyzalski

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Onofre DeJesus

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

W Douglas Brown

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

language of work or name

English

0 references

publication date

29 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

614-620

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease

27 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080432

Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080432

Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080432

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080432

Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080432

Surrogate end points in clinical trials: are we being misled?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080432

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080432

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080432

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080432

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080432

Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3080432

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

8 July 2018

1 reference

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

21 January 2018

1 reference

[(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease

21 January 2018

1 reference

Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex

21 January 2018

1 reference

Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity

21 January 2018

1 reference

Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study

21 January 2018

1 reference

An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease.

21 January 2018

1 reference

FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa.

21 January 2018

1 reference

PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease.

21 January 2018

1 reference

Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.

21 January 2018

1 reference

Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study.

21 January 2018

1 reference

Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study

21 January 2018

1 reference

Fluorodopa F 18 positron emission tomography and the progression of Parkinson disease.

21 January 2018

1 reference

Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms

21 January 2018

1 reference

Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease.

21 January 2018

1 reference

"Absolute" or "relative": choosing the right outcome measure in neuroimaging.

21 January 2018

1 reference

Gender differences in Parkinson's disease

21 January 2018

1 reference

MRI as an outcome in multiple sclerosis clinical trials

21 January 2018

1 reference

Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21449008

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21449008

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/MDS.23503

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21449008%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference